Newsroom
Sorted by: Latest
-
Restorative Spine Center of NY Launches Boutique Destination for Advanced Minimally Invasive and Restorative Spine Care
RONKONKOMA, N.Y.--(BUSINESS WIRE)--Restorative Spine Center of NY launches, offering minimally invasive, endoscopic, motion-preserving and robotic spine surgery....
-
Dompé somministra la dose al primo paziente nello studio di fase 3 su cenegermin-bkbj per la NAION
MILANO & SAN MATEO, Calif.--(BUSINESS WIRE)--Dompé, azienda biofarmaceutica con attività in Italia e negli Stati Uniti, ha annunciato l’arruolamento del primo paziente in uno studio di fase 3 su cenegermin-bkbj per il trattamento della neuropatia ottica ischemica anteriore non arteritica (NAION). Con la partecipazione di oltre 130 centri in tutto il mondo, il trial di fase 3 “Galassia-NAION-301” è uno studio multicentrico e in doppio cieco che confronta cenegermin-bkbj rispetto al placebo nel m...
-
Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION
MILAN & SAN MATEO, Calif.--(BUSINESS WIRE)--Dompé advances cenegermin-bkbj into Phase 3 for NAION, a rapid vision-loss condition with no FDA-approved treatment options....
-
Oso Internet Solutions brings fiber broadband to one of the most remote Navajo communities with Adtran
RAMAH, N.M.--(BUSINESS WIRE)--Adtran today announced that Oso Internet Solutions is using its scalable broadband technology to bring reliable, high-speed connectivity to the Ramah Navajo Indian Reservation. The locally owned provider has built a fiber-led broadband network, combining robust infrastructure with flexible last-mile access to deliver consistent, reliable performance and support sustained growth in one of New Mexico’s most remote and underserved regions. The network provides a criti...
-
Dompé dient de eerste patiënt een dosis toe in het fase 3-onderzoek naar Cenegermin-bkbj voor NAION
MILAAN & SAN MATEO, Calif.--(BUSINESS WIRE)--Dompé, een toonaangevend biofarmaceutisch bedrijf met activiteiten in Italië en de VS, maakt bekend dat de eerste patiënt is ingeschreven voor een fase 3-onderzoek naar cenegermin-bkbj voor de behandeling van niet-arteriële anterieure ischemische neuropathie (NAION). De fase 3-studie "Galassia-NAION-301", waaraan wereldwijd meer dan 130 centra deelnemen, is een multicenter, dubbelblind onderzoek waarin cenegermin-bkbj wordt vergeleken met een placebo...
-
New Oxford Economics Study Shows the Social and Economic Impact of Bars
LONDON--(BUSINESS WIRE)--Bars are major social and economic contributors to communities around the world, according to new research conducted by Oxford Economics. The study, commissioned by AB InBev, examined the economic and social impact of bars across five global markets — Brazil, Mexico, South Korea, the United Kingdom, and the United States. Across the markets surveyed, 77 percent agree that bars bring people together by creating a shared atmosphere; 72 percent agree bars make a positive e...
-
PennyMac Mortgage Investment Trust Announces Date for Release of Second Quarter 2026 Results
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--PennyMac Mortgage Investment Trust (NYSE: PMT) will announce results for the quarter ended June 30, 2026, in a news release to be issued after the market close on Wednesday, July 29, 2026. Management will host a conference call and live audio webcast at 6:00 p.m. Eastern Time to review the results.The release, webcast, and accompanying materials will be available online at pmt.pennymac.com. A replay of the webcast will be available shortly after its con...
-
Zayo Announces Planned CEO Transition as Company Enters Next Phase of AI-Driven Digital Infrastructure Growth
DENVER--(BUSINESS WIRE)--Zayo (“the Company”), the leading digital infrastructure network provider, today announced a planned CEO transition, appointing former Verizon executive Sowmyanarayan Sampath as Chief Executive Officer (CEO), effective September 1, 2026. Sampath will succeed Steve Smith, who will retire as CEO following a transformative tenure that established Zayo as the foundational backbone of the AI economy. Smith will continue to serve as a member of Zayo’s Board of Directors. Unde...
-
Dompé administra la dosis al primer paciente en el estudio de fase 3 de cenegermin-bkbj para NOIANA
MILÁN & SAN MATEO, Calif.--(BUSINESS WIRE)--Dompé, una compañía biofarmacéutica con operaciones en Italia y los Estados Unidos, anunció la inscripción del primer paciente en un estudio de fase 3 de cenegermin-bkbj para el tratamiento de la neuropatía óptica isquémica anterior no arterítica (NOIANA). Con la participación de más de 130 centros en todo el mundo, el ensayo de fase 3 “Galassia-NAION-301” es un estudio multicéntrico y doble ciego que compara cenegermin-bkbj con un placebo para la mej...
-
ChargePoint and Onvo Expand Highway Fast Charging Across the Northeastern U.S.
CAMPBELL, Calif.--(BUSINESS WIRE)--ChargePoint (NYSE: CHPT), a global leader in electric vehicle (EV) charging solutions, and Onvo, a locally owned travel plaza brand headquartered in Scranton, PA, today announced a commitment to deploy ultra-fast EV charging stations at travel plazas along major highways across the northeastern United States.The initial planned rollout includes twelve Onvo locations in Pennsylvania and New York, each featuring ChargePoint Express Plus fast charging stations des...